Bridgewest Perth Pharma Pty. Ltd is a subsidiary of the private equity firm Bridgewest Group and the parent company of NovaCina and LumaCina. Bridgewest Perth Pharma brings together innovative life sciences and talented people to meet the escalating demand for high quality drug manufacturing and therapeutics. In conjunction with the Australian Government and the country's reputation for ease of business and high-quality pharma production, Bridgewest Perth Pharma is playing a critical role in escalating the region's pharmaceutical industry to global leader.